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Thank you very much for your letter dated 16
th
 April 2020, attached with a detailed reviewers’ report. 
We are grateful for the comments and analysis. 
 
The changes to the manuscript are highlighted using tracked changes. We have tried to facilitate the 
review of the changes in the Point by Point Response for the editor by referring to the page numbers 
and lines in the manuscript. However, the format in a Word document can change, depending on the 
page format and printer selected, as well as if the Word document is accessed using the Mac or 
Windows version.  We are submitting both the Manuscript with tracked changes and the Point by 
Point Response in PDF format.  
We have addressed the comments from the reviewers as follows: 
 
Review comment Authors’ response Change to 
manuscript 
Editor 
1. The rate of primary Caesarean section in 
women at term with a cephalic presentation is 
21.9% in this cohort. This does not include 
women with a previous Caesarean section. Is 
this rate not too high? How can you explain it?  
 
Thank you for your comment. 
We would like to clarify that our study only 
included pregnancies with induced labour. We 
apologize if this was unclear in the text. 
In the nulliparous term cephalic group 
(=Robson group 2; induced labor) the CS rate 
was 21.9%. This is slightly lower than 
national figures from The Medical Birth 
Registry of Norway for 2017. The proportions 
also correspond to international literature.  
We have clarified the inclusion criteria in the 
text. 
See Methods 
Page 7, line 10. 
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2. Failed IOL was observed in 21.6% of this 
sub-group. How can you explain such a high 
percentage? Please discuss this issue. 
We do not perceive a failed induction of labor 
rate of 21.6% in women without a previous 
vaginal birth to be particularly high, although 
we would clearly aim to have a lower failed 
induction rate in these groups. In comparison, 
a Finnish study published in 2015 showed a 
caesarean section rate of induced nulliparous 
women to be nearly double – 39.1% (Kruit H 
et al. Management of foley catheter induction 
among nulliparous women: a retrospective 
study. BMC 2015. doi: 10.1186/s12884-015-
0715-9. 
 
Reviewer 1   
This was a multicenter prospective 
observational study among women who had an 
induction of labour and no previous vaginal 
birth.  The primary outcome was caesarean 
section. The main study factors were indication 
for induction and method of induction. 
The study was well-written and addressed a 
topic likely to be of interest to AOGS readers. 
The data presented are interesting because the 
current literature surrounding caesarean section 
rates by indication for induction of labour is 
sparse. 
 
Thank you for this comment.   
The authors have not explicitly stated that their 
manuscript was reported according the 
STROBE guidelines for reporting observational 
studies. 
 
Thank for this observation. We have added a 
sentence that states that the manuscript 
followed the STOBE guidelines for cohort 
studies. We have added a reference. 
Material and 
Methods, Page 7, 
lines 11-12 
Reference no. 18. 
 
A paper that may interest the authors is:  
DE VRIES BS, BARRATT A, MCGEECHAN 
K, et al. Outcomes of induction of labour in 
nulliparous women at 38 to 39 weeks pregnancy 
by clinical indication: An observational study. 
Aust N Z J Obstet Gynaecol 2019;59:484-92. 
 
Thank you for drawing our attention to this 
paper. We have included the paper in the 
Reference list and in the Discussion. 
Discussion, page 
11, line 27. 
Reference no. 26. 
A sample size calculation was performed based 
on comparing two groups of birth units with 
different methods for induction of labour.  The 
calculation is based on a difference in caesarean 
section rates between two methods of 25% 
compared with 20% but does not specify an 
alpha-value or power/beta-value.  It also does 
not specify a ratio for the prevalence of the two 
different methods (‘allocation ratio’).  The 
calculation (presumably performed before the 
study commenced) estimated 2500-3000 
participants would be required but the 
investigators estimated they would recruit 2250 
participants during the study period (and only 
1818 were actually recruited).  Thus, the study 
seems to have been planned to be 
underpowered.   
 
Additionally, the results of the primary analysis 
(for the primary study factor, primary outcome 
measure, and the results based on the sample 
We planned this study as a pilot study, as we 
did not know the true proportions and 
variation of percentage of CS according to 
induction regime in women without a previous 
delivery. 
It was also a pilot study in terms of methods 
as we used a web-based e-CRF for gathering 
of data. Thus, we attempted a power 
calculation. We defined the significance level 
(alpha) as 0.05 and power (beta) at 0.80. We 
have erroneously reported a calculation of 
inclusion of 2500-3000 women as necessarily. 
The correct number of women is 2182 (1091 
in each group).  
All 22 departments initially agreed to 
participate. However, one department (Bærum 
Hospital, n=1550 annual births) withdrew 
from participation after the study start, whilst 
one department (n=880 annual births) were 
not able to register until the last month of the 
inclusion period. In addition, birth numbers 
We have added 
the term “pilot” in 
the Title, Abstract 
(line 13) , 
Introduction, Page 
6, line 24 and 
Material and 
Methods, Page 7, 
line 3. 
 
We have specified 




methods, Page 8, 
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size calculation) are presented in a 
supplementary table, not one of the main tables. 
 
I would suggest more details are provided for 
the sample size calculation and why the 
calculation exceeded the planned study size of 
2250.  I think the results currently in the 
supplementary table (S1) should be presented in 
the main paper given that they are the main 
results of the paper based on the stated aims and 
sample size calculation. 
were unfortunately particularly low during the 
autumn of 2018, as part of a general 
downwards trend in birth numbers in Norway. 
Thus, we did not manage to recruit the target 
number. 
 
We agree that the results of the primary results 






We now present 
the primary 





Importantly, the investigators have described 
the results by Robson Group allowing 
comparisons with other settings. 
 
Thank you for this comment. As the Robson 
classification allows for comparison across 
countries and departments, we believe it is a 
useful tool for our study. 
 
In the discussion the study was referred to as a 
pilot study (page 13 line 25) but I cannot see 
indication in the introduction or methods that 
this was a pilot study. 
 
The study was planned as a pilot study, as we 
did not know the proportions of CS according 
to induction regime in women without a 
previous vaginal delivery.  
We have added 
the term “pilot” in 
the Title, Abstract 
(line 13) , 
Introduction, Page 
6, line 24 and 
Material and 
Methods, Page 7, 
line 3. 
Methods: 
I miss a definition for failed induction of labour 
– this is very important as there is much 




The departments used national and/or regional 
protocols for the definitions of indications for 
CS. In the guidelines for the Norwegian 
OBGYN Society that most birth departments 
follow, the chapter “Augmentation of labour” 
defines start of labour as regular contractions 





The diagnosis “failed induction” is normally 
used for women who did not reach this stage 
of labour.  
This has been 
stated in Material 
and Methods, 
Page 7, lines 15-
16. 
Describing the two main groups as ‘term 
cephalic’ and ‘VBAC’ does not seem correct as 
many women in the VBAC group will have a 
term cephalic presenting fetus.  Can the authors 
think of an alternative name for the ‘term 
cephalic’ group? 
Thank you for this comment. 
We have struggled to name these groups. We 
have changed the classification to 
“Nulliparous term cephalic”, “Previous CS” 
and “Other” Alternatively, the terms “Robson 
group 2” , “Robson group 5” and “Other 







A lot of the results are reported in very general 
terms e.g. ‘one in five’, ‘rates were doubled’, 
‘around half’.  These terms are imprecise, and it 
may be better to report actual percentages. 
Thank you for this comment. 
We have changed the general terms to the 
specific percentages, as suggested throughout 
the text, except for in the 1
st
 paragraph in the 
Discussion. 
 
A comparison between university and non-
university hospitals is presented (page 11 line 
42).  However, this comparison is not 
mentioned in the methods so far as I could see.  
On the other hand, the methods and sample size 
calculation state a planned comparison between 
two groups based on different methods of 
induction of labour.  The results of this planned 
comparison are not presented in the results 
except in the supplementary table which is only 
Thank you for this observation. We have 
added a comparison of CS rates between 
university and non-university hospitals in the 
Material and Methods. 
 
As mentioned above, we have now included 
the results of the planned comparison between 
two groups based on different methods of 




Methods, page 7, 
lines 16-17. 
 
We now present 
the primary 
analysis in Table 
5 (previously 
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referred to in the discussion.  I think that this 





For Figure 3, it would be interesting to see a 
breakdown by indication for caesarean section 
for each category of indication for induction of 
labour (e.g. prolonged labour/suspected 
hypoxia/failed induction)  
We do have data on this and have supplied it 
in a Supporting Information table; however, 




Results, Page 9, 
line 16. 
The authors report 42 different combinations of 
methods of induction of labour (page 12 line 8) 
but I can only see 16 combinations in Table 4.  
Can the authors make the reason for this clearer 
in the manuscript? 
Thank you for this observation. To clarify, we 
found 42 different combinations of methods; 
however, this included also method sequence 
and dosage. In Table 4 we have grouped the 
most important findings. 
We have clarified 
this in Results, 
Page 9, lines 25-
29.  
Regarding the multivariable analysis: 
For the results in the supplementary table, I 
presume logistic regression was used.  Can the 
authors confirm if the assumption of linearity of 
the regression was tested and if any tests for 
interaction were performed?  I note the models 
are adjusted for birthweight and pre-pregnancy 
BMI as continuous variables which may not be 
appropriate if the assumption of linearity was 
not met.  These details could be included in the 
statistical section of the methods.  It is plausible 
that low birthweight is associated with 
caesarean section for suspected hypoxia and 
high birthweight is associated with caesarean 
section for prolonged labour in which case 
birthweight is not expected to have a linear 
relationship with the outcome. 
A major limitation of the multivariable analysis 
is that many variables that could be associated 
with the outcome of caesarean section are not 
adjusted for (e.g. indication for induction, 
maternal hypertension)  
Thank you for this remark. 
We used general linear models in logistic 
regression analysis frameworks and have 
clarified this in the manuscript. 
 
To check for linearity regarding prepregnancy 
BMI and birthweight we also conducted 
analyses with log10-transformed variables; 
however, the results did not change. 
 
We agree with the stated limitations to the 
interpretation of findings in the regression 
analyses. Unfortunately, this study did not 
have the power to adjust for indication for 
induction and comorbidity. 
 
See Material and 
Methods, Page 8, 
lines 13-15. 
 
We have added a 
sentence to the 
Material and 
Methods, Page 8, 
lines 16-18. 
Page 12 line 30: would it make sense to remove 
the words “other administration forms of”? 
Thank you for this suggestion which has been 
implemented. 
Removed 
wording, page 10, 
line 1-2. 
The authors state that maternal blood loss 
differed between groups (page 12 line 39).  I 
presume the groups are term cephalic and 
VBAC – suggest this is stated explicitly.  Also, 
a p-value of 0.049 is quoted but I can see no 
indication of what test of statistical significance 
was performed (e.g. ttest, Wilcoxon rank sum 
test, or chi-squared test based on the categories 
on the table).  Suggest the methods used are 
included in the statistical analysis section of the 
methods and made clear in the text of the 
results. 
We found differenced in blood loss between 
the three obstetric groups (nulliparous term 
cephalic, previous CS and other groups. We 




Methods, page 8, 
lines 12-13. 
Results, page 10, 
line 4. 
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Page 12 line 44: 
‘Among the 7 cases of umbilical artery 
pH<7.00, only 2 infants had an Apgar score of 
less than 7 at 5”; 6/7 cases in the term cephalic 
group and 1/7 case in the VBAC group (the 
latter case diagnosed with uterine rupture).’ 
 – I found this paragraph a little confusing.  It 
may be clearer to report the total numbers of 
low pH and low Apgar score separately.  I don’t 
think it’s necessary to report on the frequency of 
low Apgars among the 7 infants with a low 
umbilical cord pH. 
Thank you for noticing this. We have changed 
the paragraph for better clarity. 
See changes in 
Results, page 10, 
lines 7-9. 
Discussion: 
Page 13 Suggest insert the word ‘about’ before 
‘two out of five’ (line12) and ‘one out of five’ 
(line 14). 
Page 13 line 25 – if this is a pilot study, suggest 
stating this in the title and methods – otherwise 
remove the word ‘pilot’ from the discussion.  
This study seems large for a pilot study. 
 





See comments above. 
See changes in 
Discussion, page 
10, lines 17-18. 
Page 13 line 42 – I found the sentence starting 
‘Other birth unit characteristics…’ difficult to 
understand – could the authors consider 
rewording this? 
 
We agree. The sentence has been deleted. Deleted sentence, 
Discussion, page 
10, line 30. 
Minor comments/typos: 
Page 11 line 31 replace ‘common indication’ 
with ‘common indications’ 
 
The sentence has been reworded. See changes, page 
9, line 8. 
Page 11 line 33 replace ‘was indication’ with 
‘was an indication’ 
 
The sentence has been reworded. See changes, page 
9, line 8. 
Page 12 line 42 replace ‘group’ with ‘Groups’ 
 
The sentence has been reworded. See changes, page 
10, line 6. 
Page 12 line 46 – I am used to 5’ referring to 5 
minutes and 5” referring to 5 seconds. 
 
Thank you for correcting this point. The 
sentence has been reworded. 
See changes, page 
10, line 7. 
Page 14 line 3 – could remove the words: ‘that 
explains these numbers’. 
The sentence has been reworded See changes, page 
11, line 6. 
Reviewer 2   
I read with an interest of this manuscript on 
different methods of induction at terms for 
women who did not have vaginal birth before. 
Authors have retrieved data over the period of 
four months and included 1874 women. 
Overall, they have presented data well and 
message is clear. I strongly recommend them to 
analyze data at least for a period of one year to 
refine these findings more. Good luck. 
 
We thank you for this comment and agree that 
we would have preferred to continue the study 
for a longer period. Our study was concluded 
after four months. We have now changed our 
national guidelines in order to ensure 
standardized induction protocols. We hope 
that we will at a future opportunity be able to 
do a new prospective national registration 
using the same study design, to see if the 




All authors have reviewed and approved the revisions. 
Yours sincerely, 
 
Dr. Ingvil Krarup Sørbye 
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Induction of labor has become an increasingly common obstetric procedure. However, in nulliparous women 
or women with a previous caesarean section, induction of labor can pose a clinical challenge. Despite an 
overall expansion of medical indications for labor induction, there is little international consensus regarding 
the criteria for induction of labor, or for the recommended methods among nulliparous women. In this light, 
we assessed variations in the practice of induction of labor among 21 birth units in a nation-wide cohort of 
women with no prior vaginal birth.
Material and methods
We carried out a prospective observational pilot study of women with induced labor, and no prior vaginal 
birth, across 21 of the 22 Norwegian birth units.  We registered induction indications, methods and 
outcomes from Sept 1st – Dec 31st 2018 using a web-based case record form. Women were grouped into 
‘Term cephalicNulliparous term cephalic’, ‘VBACPrevious CS’  (attempted vaginal birth after caesarean 
section –and ‘Other Robson’ (Robson groups 6, 7, 8 or 10).
Results
More than 98% of eligible women (n=1818) were included. There was a wide variety of methods used for 
induction of labor. In term cephalicnulliparous term cephalic pregnancies, caesarean section rates ranged 
from 11.1 - 40.6% between birth units, whereas in the VBACprevious CS group, rates ranged from 22.7 - 
67.5%. The indications ‘large fetus’ and ‘other fetal’ indications were associated with the highest caesarean 
rates. Failed inductions and failure to progress in labor contributed most to the caesarean rates. Uterine 
rupture occurred in two women (0.11%), both in the VBACprevious CS group. In neonates, 1.6% had Apgar 
<7 at 5 minutes, and 0.4% had an umbilical artery pH <7.00.
Conclusions
Caesarean rates and applied methods for induction of labor varied widely in this nation-wide cohort of 
women without a prior vaginal birth. Neonatal outcomes were similar to that of normal birth populations. 
Results could indicate the need to move towards more standardized induction protocols associated with 
optimal outcomes for mother and baby.
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BMI body mass index
GDM gestational diabetes mellitus
IQR interquartile range
Key Message
In induction of labor among women without a prior vaginal birth, large variations in methods used and 
caesarean rates were observed in this nation-wide clinical practice evaluation.
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The worldwide rate of induction of labor has been rising steadily over the last 15 years.  Currently 
approximately 25 % of births in high-income countries are induced. (1, 2) When faced with unfavorable 
factors for the mother or the baby if pregnancy continues, induction of labor can be indicated. (3) In 
pregnancies complicated by maternal diabetes or preeclampsia, post-term pregnancies and prolonged 
prelabor rupture of membranes (PROM), induction of labor compared to expectant management reduces the 
risk of perinatal death and maternal complications. (3-7) Over the last decades an expansion of medical 
indications for labor induction has occurred, including such conditions as hypertensive disorders, (5) 
advanced maternal age, (8) gestational diabetes (GDM) (9) and suspected large fetus for gestation. (10) 
Newer studies have demonstrated the safety of induction of labor without a medical indication, with fetal 
outcomes and caesarean section (CS) rates comparable to rates among women awaiting spontaneous labor. 
(11) 
However, there are some concerns as to the generalizations of these findings into routine practice. First, 
results produced in setting with relatively high overall CS rates cannot necessarily be extrapolated to settings 
with average low CS rates. A clinical challenge is also posed by the considerable number of nulliparous 
women and women with a previous uterine scar, (12) giving birth today. , pose a clinical challenge. 
Furthermore, induction of labor is not risk-free as more interventions are performed in induced compared to 
spontaneous labors. (13, 14) Finally, in recent studies of induction of labor, few have used standardized and 
consistent protocols in terms of the methods used. There is currently no international agreement as to what is 
the best induction method in women without a prior vaginal birth, (1, 15) and there is large diversity in 
clinical practice. (1, 2)
The authors of this study considered that assessing variation in induction practices in a national sample from 
a setting with free universal public delivery care and low average CS rates, (16) such as Norway, might be a 
good start to evaluate current practices and results. The aim of this pilot study was to examine variation in 
indications for induction of labor, methods and associated CS prevalence among women with no previous 
vaginal birth across 21 birth units nationwide. We used the Robson classification framework to distinguish 
women with term cephalicnulliparous term cephalic pregnancies versus those with a previous uterine scar 
attempting a vaginal birth after caesarean section.V (17) Ultimately, we aimed to identify practices 
associated with the best outcomes in terms of maternal and neonatal safety to inform obstetric providers. 
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We carried out a prospective pilot registration of women undergoing induction of labor with a live fetus 
beyond 23 completed gestational weeks and with no prior vaginal birth between September 1st - December 
31st 2018. We invited Norwegian obstetric departments with >1000 annual births to participate in the study. 
Out of 22 eligible units, 21 units were included (Supplementary Figure A). Participating units selected 
women whose labor was to be induced and decided upon the method(s) according to local practices, 
guidelines and definitions. Out-patient induction of labor was not practiced. Anonymous individual patient 
data were prospectively registered by clinicians in each department into a web-based electronic case record 
form. Only women with induction of labor were included. The number of nulliparous women without a 
previous birth and the induction rate during the period was also reported. The paper is reported using the 
STROBE guidelines for cohort studies.(18) Data were stored in Services for Sensitive Data, University of 
Oslo, Norway. The project is registered in ClinicalTrials.gov, no. NCT03730220.(19)
The primary outcome was the occurrence of caesarean section (CS) according to indication for induction 
and method of induction, stratified by Robsonobstetric groups. Indications for CS were defined according to 
national/regional guidelines. We also assessed CS rates according to level of birth unit (university hospital 
or not). Secondary outcomes included uterine rupture, estimated maternal blood loss, adverse neonatal 
outcomes and the time interval from drug administration to birth. Estimated postpartum blood loss during 
labor and until 2 hours postpartum in ml was reported in categories. Adverse neonatal outcomes were 
defined as a composite outcome of Apgar score <7 at 5 minutes and/or transfer to neonatal intensive care 
unit and/or pH in umbilical artery <7.10 within one hour of birth. 
We categorized cases into three groups. These were: “Nulliparous nulliparous term cephalic” (Robson 2), 
"Previous CS" (classified as Robson 5: multiparous women with a previous uterine scar, no previous vaginal 
birth andwith a single cephalic term pregnancy; however with no previous vaginal birth), and “Other 
Robson”  (including Robson groups 6 and 7: women with a single breech pregnancy; Robson group 8: 
women with multiple pregnancies, and Robson group 10: women with a single cephalic pregnancy < 37 
weeks’ gestation). ‘Term cephalic’ (Robson group 2); ‘VBAC’ (attempted vaginal birth after caesarean 
section; Robson group 5: multiparous women with previous uterine scars with a single cephalic term 
pregnancy) and ‘Other Robson groups’ (including Robson groups 6 and 7: women with a single breech 
pregnancy, including previous CS; Robson group 8: women with multiple pregnancies, including previous 
CS and Robson group 10: women with a single cephalic pregnancy < 37 weeks’ gestation, including 
previous CS). 
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The indication for induction was categorized into 12 groups: Postdates (as defined locally; latest 42+0), 
PROM, preeclampsia/hypertension, intrauterine growth restriction (IUGR)/oligohydramnios, insulin-treated 
diabetes in pregnancy including insulin-treated GDM), non-insulin treated GDM, suspected large fetus, 
reduced fetal movements, intrahepatic cholestasis of pregnancy, maternal request, ‘other maternal’ and 
‘other fetal’. The starting method for induction was categorized as Foley balloon catheter, misoprostol (oral, 
vaginal insert or vaginal tablet), or dinoprostone. As according to the protocol, we performed three 
comparisons: induction regime with Foley balloon catheter versus no catheter; induction regime including 
misoprostol vaginal insert versus other misoprostol administration forms, and induction regime including 
dinoprostone versus misoprostol. 
Other covariates included maternal age in categories, pre-pregnancy body mass index (BMI) (< 30 or BMI 
≥30), gestational age at induction, Bishop score at induction ( ≤5, >5 or missing), epidural, infant 
birthweight and tachysystole (>5 contractions per 10” with abnormal fetal tracing). 
Statistical analysis
A statistical analysis plan was completed before analysis.included aA power analysis. Aassuming two 
groups of birth units with different induction methods resulting in a difference in CS rate between 20 to 
25%, a significance level (α) of 0.05, and 80% power (β), the study would would need 2500 – 30002182 
participantspatients. Applying the inclusion criteria, we estimated 2250 births during the period. (20) 
Baseline characteristics and outcomes were summarized according to the obstetric group. Small cell 
numbers (n<10) were censored when calculating CS rates. For categorical outcomes we compared 
proportions with 95% CI with the Chi-Square test and/or Fisher’s exact test. We estimated the risk of CS by 
logistic regression analysis in in generalized linear models adjusting for confounders as identified in the 
literature and according to biological plausibility, estimating crude and adjusted effect estimates as odds 
ratios (OR) with 95% CI with corresponding p-values. To check for linearity regarding continuous 
covariates, we also conducted analyses with log-transformed variables; however, the results did not change. 
We restricted analyses to term cephalicnulliparous term cephalic and VBACprevious CS only due to small 
cell numbers. In sub analyses of CS deliveries only, we determined indications for the procedure and the 
subtype (type 1- immediate delivery; type 2- within 20-30 minutes or type 3 - within a given timeframe >30 
min < 8 hours). Calculated P-values were two-sided and compared to a 5% significance level. Statistical 
analyses were performed in SPSS version 25 (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, 
Version 25.0. Armonk, NY: IBM Corp.)
Ethical approval
All women received oral and written information about the study. As routine data were gathered 
anonymously, informed consent was waivered; however, women were able to opt out of the study upon 
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request. The project was approved by the Norwegian Ethics Board, Region Health South East C, reference 
2018/1087 and each hospital’s Data Protection Officer.     
RESULTS
During the study period, a total of 7160 women without a prior vaginal birth gave birth in the 21 
participating departments. Among these, labor was induced in 1874 women (26.2%; range 11.7-34.3% 
between hospitals). Of all 1874 eligible women for inclusion in the study,1818 (98.5%) were included 
(Figure 1). Most birth units had a written induction protocol; however, most were not differentiated 
according to their Robson group.
Term cephalicNulliparous term cephalic pregnancies constituted 80.4% of births, followed by 
VBACprevious CS pregnancies (12.2%) (Table 1). The “Other Robson’ group included 52 twin pregnancies  
classified in ( (2.9%), 59 preterm births classified in ((3.2%) and 25 planned breech births (1.4%). One in 
five womenOverall, 20.3%  wereas aged 35 years or more and 18.4%. Similarly, one in five women had a 
pre-pregnancy BMI of 30 or more. The proportion of women with an unripe cervix did not differ between 
groups. Of all women, 16.6% had a registered comorbidity where preeclampsia/hypertension was most 
prevalent. PROM, postdate pregnancy and preeclampsia/hypertension were the most common indications 
for induction.  and comprised around half of all inductions. Maternal request was an indication for induction 
in only 3.5% of women.
In the term cephalicnulliparous term cephalic group, one in five women gave birth by CS, whereas rates 
were doubled in the VBACprevious CS group and in the “OOther Robson” group (Table 2). Hospital CS 
rates varied between 9.4% and 45.5% in the term cephalicnulliparous term cephalic group and between 
31.3% and 54.5% in the VBACprevious CS group (Figure 2). In the whole cohort, university hospital CS 
rates did not differ significantly from non-university hospitals (24.2% vs 26.8%, P=0.22). In the term 
cephalicnulliparous term cephalic group CS rates by indication for the induction of labor ranged from 11.1 
to 40.6%, whereas in the VBACprevious CS group rates were overall higher and ranged from 22.7 to 67.5% 
(Figure 3; Table S1.). In the term cephalicnulliparous term cephalic group ‘non-insulin GDM’, ‘other fetal’ 
and ‘large fetus’ were the indications associated with the highest CS rates (40.6-33.3%). In the 
VBACprevious CS group ‘large fetus’, ‘insulin-treated diabetes’ and ‘other fetal’ were associated with the 
highest CS rates (62.5-60.0%). 
The most common CS indication was suspected fetal hypoxia in the term cephalicnulliparous term cephalic 
group, and failed induction in the VBACprevious CS group (Table 3). Of all caesarean procedures, 9.2% 
were reported as grade 1 (immediate) (Table 3). Overall 2.1% of women in the term cephalicnulliparous 
term cephalic group and 3.6% of the VBACprevious CS group experienced an immediate CS. Suspected 
uterine rupture or abruptio placentae were indications for seven (0.4%) caesarean procedures. 
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The most common methods for induction are presented in Table 4. Altogether, more than 42 different 
combinations were registered among the 1818 women, not taking into account different modes of 
administration of misoprostol. The most common initial method was Foley catheter (59.7%) followed by 
misoprostol (28.2%) and amniotomy+/- oxytocin (7.2%). In the term cephalicnulliparous term cephalic 
group, a combination of Foley + vaginal insert misoprostol was the most common initiation method 
(37.3%), followed by Foley + oral misoprostolamniotomy/oxytocineoxytocin (11.9%) (Table 4). In the 
VBACprevious CS group, most womenone third of women received Foley + dinoprostone (34.4%), as the 
most common method, followed by Foley + amniotomy/ and/or oxytocin.  Amniotomy as part of the 
induction was recorded in 46.9% in the term cephalic group and in 52.2% in the VBAC group, whereas 
oxytocin as an induction agent was used in 31.7% and 36.7% correspondingly. However, altogether, more 
than 40 different method combinations and sequences were registered.
Use of Foley catheter was associated with birth by CS in the term cephalicnulliparous term cephalic group 
(aOR 1.78, 95% CI 1.16-2.59, p=0.008), but not in the VBACprevious CS group (aOR 0.63, 95% CI 0.19-
2.07, P=0.45) (Supplementary Table 5A). Use of dinoprostone showed a borderline significant association 
with birth by CS compared to other administration forms of misoprostol in crude, but not in adjusted 
analyses. There was no association between route of administration of misoprostol and risk of CS (data not 
shown).
Uterine rupture occurred in two women (0.11%), both in the VBACprevious CS group (Table 65). Maternal 
blood loss differed between groups (p=0.049, Chi-Square); however, tachysystole did not. The composite 
adverse infant outcome occurred in 9.5% and 10.0% in the around one out of ten deliveries in term 
cephalicnulliparous term cephalic and the previous CS group respectivelyand VBAC births. A higher 
proportion (30.9%) was found in the Other Robson groups due to more transfers to the neonatal ward due to 
prematurity. Overall Among the29 infants (1.6%) had an Apgar score of less than 7 at 5’. Seven infants 
(0.4%) had 7 cases of an umbilical artery pH<7.00, of whom , only 2 infants had an Apgar score of less than 
7 at 5”; 6/7 cases in the term cephalic group and 1/7 case in the VBAC group (the latter case diagnosed with 
uterine rupture). Only one infant out of the seven infants with pH <7.00 was transferred to the neonatal 
ward. The method of induction was not significantly associated with adverse maternal or neonatal outcome. 
Among term cephalicnulliparous term cephalic births, 26.5% were still undelivered 48 hours after start of 
induction start, as were 31.6% in the VBACprevious CS group and 26.5% in the Other Robson group (data 
not shown). In the three groups Mmedian duration from start of induction to birth in the were term cephalic 
group was 32.6 hours (IQR 31.8), in the VBAC group 34.1 hours (IQR 35.1) and in the Other Robson group 
and 30.6 hours (IQR 32.6), respectively. 
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Our study showed large variations in the practice and results of induction of labor in this nation-wide 
sample. The frequency of CS after induction of labor was highest in the VBACprevious CS group, where 
about two out of five  women gave birth by CS and lowest in the term cephalicnulliparous term cephalic 
group, where about one out of five  women gave birth by CS. CS rates after induction differed widely 
between units. CS performed due to failed induction of labor and prolonged first stage of labor accounted for 
nearly half of all CS in our study group. Our study also found a wide variation of induction methods, with 
few units using standard induction protocols. Maternal and fetal safety outcomes were comparable to 
existing literature.  
The strengths of this pilot study include the nation-wide prospective design with more than 98% of eligible 
women included. We had access to detailed information regarding indications, the different methods used, 
including the order and route of administration, as well as important safety and efficiency outcomes.
One of the limitations of the study is that we lacked control data from induced multiparous women as well 
as on spontaneous labors. For this reason, we cannot comment on whether induction increases the rate of CS 
or adverse outcomes compared to spontaneous birth. Furthermore, we lacked detailed data on the local birth 
units, such as the number of referrals, socioeconomic spread etc. that might influence outcomes in terms of 
mode of birth. In the VBACprevious CS group we lacked information regarding the previous birth. Other 
birth unit characteristics than methods diversities than induction methods might have affected CS rates, such 
as unregistered maternal or fetal comorbidities. However, CS rates were slightly lower in tertiary referral 
university hospitals compared to non-university hospitals, where an accumulation of risks would be 
expected. Finally, our observational design does not warrant causal inference. 
Induction by “large fetus” indication revealed high rates of CS in our study. However, the CS rate at 33.3% 
is similar to other studies of induction in woman with ‘large babies. In the comprehensive study by Boulvain 
et al, (10) there was a CS rate of 28%, even though 53% were parous. These rates might be the result of a 
high gestational age in combination with maternal diabetic comorbidity that explains these numbers. GDM 
non-insulin comorbidity had the highest CS rate whereas insulin-treated pregestational or gestational 
diabetes comorbidity had a relatively low CS rate in term cephalicnulliparous term cephalic pregnancies.  In 
Norway, insulin users are induced between week 38 and 40, but non-insulin GDM are induced primarily on 
additional indications. (21)
“Other fetal indication” for induction of labor had one of the highest CS rates in both nulliparous term 
cephalic and previous CS pregnancies. This is a mixed group including fetal malformations, 
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polyhydramnios, non-reassuring antenatal fetal tracing and unknown gestational length. Polyhydramnios 
may give insufficient contractions due to an over distended uterus (22) and non-reassuring fetal tracing have 
to be handled with care; delivery, rather than expectant management is preferred, if it continues. The group 
“maternal request” was surprisingly low with 3.5 % of all inductions and we found a low CS rate both in the 
term cephalicnulliparous term cephalic and the VBACprevious CS group.  This is lower than previously 
reported. (23) The distinction between ‘maternal request’ or ‘medical problem’ can be a fine one, especially 
when considering mental health and pregnancy complaints. However, this finding indicates a restrictive 
attitude among providers, in contrast to upcoming trends elsewhere. (24) 
The overall proportion of failed induction and prolonged first stage was unexpectedly high in our sample. 
However, as 27-32% of women were undelivered 48 hours after the start of induction, this is not likely to 
reflect a use of rigid time limits.  The 22-35% rate of failed induction/poor progress in the first stage that we 
found in our sample might imply a practice emphasizing safety rather than effectiveness. This is also 
reflected in a relatively low uterine rupture rate, a low tachysystole rate of 5% and few immediate CS 
procedures.  
At present, there are conflicting reports of how and when induction of labor should be offered to women. 
Trials have been conducted among women at term with no medical indication. (11, 25, 26) These 
randomized trials indicate no major safety concerns in terms of the CS risk or adverse infant or maternal 
outcomes. In addition, although the ARRIVE trial has been criticized as including many overweight and 
obese women, (27) the 18.6% CS rate in the ARRIVE trial’s  induced group (who were all low risk 
nulliparous women) is similar to the 16.7% rate seen in ‘maternal request’ in the term cephalicnulliparous 
term cephalic group in our study. A Cochrane review looking at induction at 40 weeks versus expectant 
management found improved outcomes in the induction group, xcept for a higher operative vaginal 
delivery rate. (3) However, a prerequisite in generalizing findings is that the induction process and labor is 
well managed with the necessary staff at hand. Like most high-resource countries, Norway has a rapidly 
increasing induction rate that reached 23% of all births in 2018 (20), but at the same time, overall CS rates - 
16.0% in 2017 – are very low, the second lowest rate across the OECD area (16). However, CS rates vary 
considerably between regions beyond what can be expected due to case-mix. (28) A national induction 
guideline lists medical indications and methods, but leaves the choice among these methods to individual 
departments and staff. (21) In this clinical practice evaluation, we found that multiple induction protocols 
are used even within term cephalicnulliparous term cephalic and VBACprevious CS groups. What this 
means is that women across the country do not have similar treatment when undergoing induction of labor. 
Translating RCT evidence into practical clinical protocols can be challenging in obstetric units facing 
logistical restraints such as delays in timely administration of uterotonics and performing rupture of 
Page 19 of 73
http://www.aogs-online.com































































membranes. (29) Results from practice evaluations are therefore important to inform decisions in induction 
regimes tailored to specific groups. Women should be offered joint decision making based on these facts. 
Careful selection of women for induction who have previously had a caesarean section, as well as taking 
women’s personal preferences into account, are important factors in a pragmatic induction of labor protocol. 
CONCLUSION
A wide variation of induction methods and CS rates after induction, as well as a high rate of failed 
inductions in women without a prior vaginal birth, points to a potential for improvement by moving towards 
more standardized protocols. The Robson groups provide a framework for the counselling of women about 
particular risks and benefits regarding induction of labor while working towards shared decision-making.
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Tweetable abstract: 
There is considerable variation in outcomes after induction of labor, depending on where a primiparous 
woman chooses to have her birth.  
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Legends of supporting information
Supporting Information Table S1 Method and risk of caesarean section among women in the term cephalic 
and VBAC groups.
Supporting Information Figure 1 Map of participating birth units in Norway.
Legends of Tables and Figures
Table 1 Maternal characteristics in 1818 women with no prior vaginal birth undergoing induction of labor.
Table 2 Delivery mode after induction of labor in 1818 women with no prior vaginal birth according to 
obstetric group.
Table 2 Delivery mode in term cephalic, VBAC and Other Robson groups in women with no prior vaginal 
delivery
Table 3 Main indication and subtype of 459 caesarean sections1 after induction of labor according to 
obstetric group.in term cephalic, VBAC and Other Robson groups.
Table 4 Induction methods in 1818 women with no prior vaginal birth according to obstetric group. term 
cephalic, VBAC and Other Robson groups in 1818 women with no prior vaginal birth.
Table 5 Method and risk of cesarean section in nulliparous term cephalic and previous CS pregnancies after 
induction of labor.
Table 6 Maternal and fetal secondary outcomes after induction of labor according to obstetric groups.Table 
5 Maternal and fetal secondary outcomes in term cephalic, VBAC and Other Robson groups for 1818 
women with no prior vaginal birth.
Supporting information Table S1. Indication for induction according to indication for CS in three obstetric 
groups.
Figure 1 Flowchart of study participants
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Figure 2 Proportions of caesarean section after induction of labor by delivery unit in the term 
cephalicnulliparous term cephalic (a) and VBACprevious CS pregnancies (b).
Figure 3 Caesarean section rates according to indication for induction of labor 
in Term cephalicnulliparous term cephalic and VBACprevious CS groupspregnancies.
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<30 1458 81.6 1185 82.3 160 74.8 113 85.0
>= 30 328 18.4 254 17.7 54 25.2 20 15.0
Bishops score2
0-5 1366 82.8 1077 81.8 185 88.9 104 83.2
6-10 284 17.2 240 18.2 23 11.1 21 16.8
Birth at University hospital 
Yes 1173 64.5 957 65.5 124 56.1 93 68.4
Gest. age median (IQR) 40+1 (21) 40+3 (18) 40+0 (18) 36+5 (16)
Maternal comorbidity3
IDDM/GDM insulin 137 7.5 105 7.2 22 10.0 10 7.4
GDM, non-insulin 91 5.0 74 6.4 7 3.2 10 7.4
Preeclampsia/ hypertension 238 13.1 189 12.9 13 5.9 37 27.2
Intrahepatic cholestasis 34 1.9 25 1.7 6 2.7 3 2.2
Another comorbidity 272 15.0 210 14.4 39 17.6 23 5.9
Decision induction
Consultant 1181 65.0 897 61.4 162 72.4 123 90.4
Resident 534 29.4 472 32.3 49 22.2 13 9.6
Midwife 103 5.7 93 6.4 10 4.5 0 0
Main indication for induction
PROM 357 19.3 286 19.6 47 21.3 24 17.6
Postdates 336 18.5 299 20.5 33 14.9 4 2.9
Preeclampsia/hypertension 279 15.3 228 15.6 17 7.7 34 25.0
IUGR/oligohydramnios 280 15.4 231 15.8 24 10.9 25 18.4
IDDM/GDM - insulin 97 5.3 81 5.5 13 5.9 3 2.2
Large fetus 67 3.7 45 3.1 16 7.2 6 4.4
Maternal request 61 3.5 36 2.5 22 10.0 3 2.2
GDM, non-insulin 35 1.9 32 2.2 3 1.4 0 0
Intrahepatic cholestasis 43 2.4 35 2.4 5 2.3 3 2.2
Reduced fetal movements 40 2.2 36 2.5 3 1.4 1 0.7
Other maternal4 164 9.0 101 6.9 33 14.9 30 22.1
Other fetal5 59 3.2 51 3.5 5 2.3 3 2.2
Term cephalicOther Robson includes Robson groups 6, 7, 8 and 10. BMI= Body Mass Index. IQR=interquartile range. 
IDDM=insulin-dependent diabetes mellitus. GDM=gestational diabetes mellitus. PROM=prelabor rupture of 
membranes. IUGR=intrauterine growth restriction.1Missing 1.8%. 2Not assessed in 9.2%. 3More than one condition 
might be registered. 4Incl. twin pregnancy, previous obstetric history, chronic disease, prolonged latency phase, 
vaginal bleeding. 5incl. polyhydramnios, non-reassuring fetal tracing, known malformations, unknown gestational 
length.
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Table 2 Delivery mode after induction of labor in 1818 women with no prior vaginal birth according toin 
term cephalic, VBAC and Other Robson groups in women with no prior vaginal delivery obstetric group.
Caesarean section1 Operative vaginal Spontaneous vaginal
N  n % 95% CI n % 95% CI n % 95% CI
Term cephalicNulliparous term cephalic 1461 320 21.9 19.8-24.1 314 21.5 19.4-23.7 827 56.6 54.0-59.2
VBACPrevious CS 221 89 40.3 33.7-47.1 40 18.1 13.3-23.8 92 41.6 35.1-48.4
Other Robson 136 50 36.8 28.9-45.8 28 20.6 14.2-28.6 60 44.1 35.9-53.2
All 1818 459 25.2 23.3-27.3 382 21.0 19.2-23.0 979 53.9 51.5-56.2
“Term cephalic“Other” Robson includes Robson groups 6, 7, 8 and 10. 1Including caesarean section second twin.
Table 3 Main indication and subtype of 459 cesarean sections1 after induction of labor according to obstetric 
group.Table 3 Main indication and subtype of 459 caesarean sections1 in term cephalic, VBAC and Other 
Robson groups.








n=459 % n=320 % n=89 % n=50 %
Main caesarean indication
Prolonged 1.stage 117 25.5 85 26.6 23 25.8 9 18.8
Prolonged 2. stage 26 5.7 19 5.9 4 4.5 3 6.5
Susp. fetal hypoxia 143 31.2 112 35.0 19 21.3 12 25.0
Failed induction 109 23.7 69 21.6 31 34.8 9 18.8
Uterine rupture 2 0.4 0 0 2 2.2 0 0
Abruptio placentae 5 1.1 3 0.9 1 1.1 1 2.1
Other 55 12.0 31 9.7 10 11.2 14 29.2
Subtype
Type 1 (immediate) 42 9.2 30 9.4 8 9.0 6 12.0
Type 2 (<20 minutes) 234 51.0 172 53.8 36 40.4 26 52.0
Type 3 (>20 minutes) 181 39.4 118 36.9 45 50.6 18 36.0
1Including caesarean section of second twin only (n=2). “Term cephalic“Other” Robson includes Robson groups 6, 7, 
8 and 10. 
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Table 4 Induction methods in 1818 women with no prior vaginal birth according to obstetric group.Table 4 
Induction methods in term cephalic, VBAC and Other Robson groups in 1818 women with no prior vaginal 
birth.





Induction method N=1818 % N=1461 % N=221 % N=136 %
Foley start combinations
Foley alone 135 7.4 102 7.0 19 8.6 14 10.3
Foley + oral misoprostol  ± 
AT/oxytocin
191 10.5 178 12.2 4 1.8 9 6.6
Foley + insert misoprostol ± 
AT/oxytocin
198 10.9 190 13.0 1 0.5 7 5.1
Foley + vaginal misoprostol ± 
AT/oxytocin
213 11.7 177 12.1 11 5.0 25 18.4
Foley + dinoprostone ± AT/oxytocin 108 5.9 28 1.9 76 34.4 4 2.9
Foley ± AT/oxytocin 241 13.3 174 11.9 49 22.2 18 13.2
Misoprostol start combinations
Oral misoprostol alone 118 6.5 107 7.3 1 0.5 10 7.4
Oral misoprostol ± AT/oxytocin 45 2.5 41 2.8 0 0 4 2.9
Insert misoprostol alone 67 3.7 66 4.5 0 0 1 0.7
Insert misoprostol ± AT/oxytocin 29 1.6 28 1.9 0 0 1 0.7
Vaginal misoprostol alone 165 9.0 148 10.1 3 1.4 14 10.3
Vaginal misoprostol ± AT/oxytocin 88 4.8 79 5.4 1 0.5 8 5.9
Other combinations
Dinoprostone alone 39 2.1 9 0.6 26 11.8 4 2.9
Dinoprostone ± AT/oxytocin 11 0.6 2 0.1 8 3.6 1 0.7
Amniotomy ±oxytocin 130 7.2 103 7.0 19 8.6 8 5.9
Any misoprostol/dinoprostone + 
successive Foley ± AT/oxytocin
24 1.3 17 1.2 3 1.4 4 2.9
Other 16 0.9 12 0.8 0 0 4 2.9
Term cephalicOther Robson includes= Robson groups 6, 7, 8 and 10. AT=amniotomy. 
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Table 5 Method and risk of cesarean section in nulliparous term cephalic and previous CS pregnancies after 
induction of labor.
                                   Proportion CS Risk of Caesarean section
CS % OR 95% CI p aOR2 a95% CI2 P2
1. Foley1 (n=1356)
Nulliparous term cephalic
Foley catheter 212 25.2 1.55 1.13-2.13 0.007 1.78 1.16-2.59 0.008
No Foley catheter 61 17.9 1 1
Previous CS
Foley catheter 60 40.3 1.08 0.46-2.54 0.86 0.63 0.19-2.07 0.45
No Foley catheter 10 38.5 1 1
2. Dinoprostone vs  misoprostol (n=1195)
Nulliparous term cephalic
Dinoprostone 14 34.1 1.80 0.93-3.49 0.082 1.49 0.74-3.01 0.26
Misoprostol 230 22.4 1 1
Previous CS
Dinoprostone 49 47.1 1.29 0.51-3.27 0.60 1.47 0.54-3.99 0.46
Misoprostol 9 40.9 1 1
1Excluding women with prelabor rupture of membranes. 2Adjusted for maternal age groups 16-24, 25-34 (ref),
 ≥35; prepregnancy BMI, Bishop score ≤5 (ref), >5 and missing; Foley catheter yes/no, and birthweight in grams.
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Table 6 Maternal and fetal secondary outcomes after induction of labor according to obstetric groups.Table 
5 Maternal and fetal secondary outcomes in term cephalic, VBAC and Other Robson groups for 1818 
women with no prior vaginal birth.





Maternal n % N % n % n %
Uterine rupture 2 0.1 0 0 2 0.9 0 0
Tachysystole 96 5.3 79 5.4 10 4.5 7 5.1
Epidural 1355 74.5 1090 74.6 157 71.0 108 79.4
Blood loss in ml
<500 1051 57.8 863 59.1 120 54.3 68 50.0
500-999 552 30.4 439 30.0 69 31.2 44 32.4
1000-1999 178 9.8 135 9.2 24 10.9 19 14.0
2000-2999 33 1.8 22 1.5 6 2.7 5 3.7
3000+ 4 0.2 2 0.1 2 0.9 0 0
Fetal1
Mean birthweight in 
grams(SD)
3485 (597) 3513 (550) 3664 (522) 2887 (808)
Adverse neonatal outcome2 203 11.2 139 9.5 22 10.0 42 30.9
Transfer NICU 132 7.4 85 5.9 10 4.6 37 27.6
Apgar <75 at 57 minutes 29 1.6 20 1.4 7 3.2 2 1.5
pH art umb <7.103 72 4.0 59 4.0 9 4.0 4 2.9
pH art umb <7.003 7 0.4 6 0.4 1 0.5 0 0
Term cephalicOther Robson includes  = Robson groups 6.7.8.and 10. 1Outcomes for first twin only. SD= standard 
deviation. 2Adverse neonatal outcome incl. pH arteria umbilicalis <7.10 and/or Apgar score at 5’” <7 and/or transfer 
neonatal intensive care unit. NICU= neonatal intensive care unit excluding planned transfers (n=18). 3Missing 19.5%.
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Figure 1 Flowchart of study participants
Not asked n=20
Did not consent n=8
21 delivery units >1000 births/year





n=1 874 (26.2%) 
Duplicate records    n=26
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Figure 2 Proportions of cesarean section after induction of labor by delivery unit in nulliparous term 
cephalic (a) and previous CS pregnancies (b).Figure 2. 
Proportions of caesarean section by delivery unit in the term cephalic (a) and VBAC pregnancies (b).
(a) Term cephalicNulliparous term cephalic 







































Term cephalicOther Robson includes= Robson groups 6, 7,8 and 10. Results from delivery units with n<10 deliveries 
per cell are censored.
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Figure 3 Cesarean section rates according to indication for induction of labor 
in nulliparous term cephalic and previous CS pregnancies.Figure 3 Caesarean section rates according to 
indication for induction of labor 
























































Previous CS                                                        Cesarean section (%)
Term cephalicGDM= gestational diabetes mellitus; IDDM= insulin-dependent diabetes mellitus; IUGR=intrauterine 
growth restriction; PROM=prelabor rupture of membranes; ICP= intrahepatic cholestasis of pregnancy. 
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Supporting information Table S1. Indication for induction according to indication for CS in three obstetric groups.













Indication Postdates 27 6 24 13 1 1 6 78
PROM 14 5 17 6 0 0 6 48
Preeclampsia/hypertension 10 4 17 13 0 0 10 54
IUGR/oligohydramnios 9 0 19 9 0 2 1 40
IDDM/GDM-insulin 1 1 6 11 0 0 0 19
GDM, non-insulin 5 0 6 1 0 0 1 13
Other maternal 4 1 8 6 0 0 2 21
Reduced fetal movements 0 0 3 1 0 0 0 4
Intrahepatic cholestasis 2 0 1 0 0 0 1 4
Maternal request 2 1 1 0 0 0 2 6
Suspected large fetus 6 1 3 4 0 0 1 15
Other fetal 5 0 7 5 0 0 1 18
















Indication Postdates 4 0 3 4 0 0 2 13
PROM 5 0 3 8 0 0 4 20
Preeclampsia/hypertension 3 0 2 4 1 0 0 10
IUGR/oligohydramnios 2 0 3 3 0 0 0 8
IDDM/GDM-insulin 1 1 2 3 0 1 0 8
GDM, non-insulin 1 0 0 0 0 0 0 1
Other maternal 3 0 1 5 0 0 1 10
Reduced fetal movements 1 0 0 0 0 0 0 1
Maternal request 2 0 1 1 0 0 1 5
Suspected large fetus 1 3 2 2 0 0 2 10
Other fetal 0 0 2 1 0 0 0 3
Total 23 4 19 31 1 1 10 89













Indications Postdates 0 0 2 1 0 0 1 4
PROM 2 1 0 0 0 1 2 6
Preeclampsia/hypertension 1 0 3 1 0 0 4 9
IUGR/oligohydramnios 0 0 4 1 0 0 4 9
IDDM/GDM-insulin 2 0 0 1 0 0 0 3
Other maternal 2 2 2 2 0 0 3 11
Reduced fetal movements 0 0 0 1 0 0 0 1
Maternal request 0 0 0 1 0 0 0 1
Suspected large fetus 2 0 1 1 0 0 0 4
Total 9 3 12 9 0 1 14 48
PROM=prelabor rupture of membranes. IUGR=intrauterine growth restriction. IDDM/GDM=insulin-dependent/gestational diabetes.
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Term cephalic = Robson group 2; VBAC =attempted vaginal birth after caesarean delivery, includes Robson group 5. 
1Excluding women with prelabor rupture of membranes. 
2Adjusted for maternal age groups 16-24, 25-34 (ref), ≥35; prepregnancy BMI, Bishop score ≤5 (ref), >5 and missing; 
Foley catheter yes/no, and birthweight in grams.
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Supporting Information Figure 1 Map of participating birth units in Norway.
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Previous CS Other 
Robson






























<30 1458 81.6 1185 82.3 160 74.8 113 85.0
>= 30 328 18.4 254 17.7 54 25.2 20 15.0
Bishops score2
0-5 1366 82.8 1077 81.8 185 88.9 104 83.2
6-10 284 17.2 240 18.2 23 11.1 21 16.8
Birth at University hospital 
Yes 1173 64.5 957 65.5 124 56.1 93 68.4
Gest. age median (IQR) 40+1 (21) 40+3 (18) 40+0 (18) 36+5 (16)
Maternal comorbidity3
IDDM/GDM insulin 137 7.5 105 7.2 22 10.0 10 7.4
GDM, non-insulin 91 5.0 74 6.4 7 3.2 10 7.4
Preeclampsia/ hypertension 238 13.1 189 12.9 13 5.9 37 27.2
Intrahepatic cholestasis 34 1.9 25 1.7 6 2.7 3 2.2
Another comorbidity 272 15.0 210 14.4 39 17.6 23 5.9
Decision induction
Consultant 1181 65.0 897 61.4 162 72.4 123 90.4
Resident 534 29.4 472 32.3 49 22.2 13 9.6
Midwife 103 5.7 93 6.4 10 4.5 0 0
Main indication for induction
PROM 357 19.3 286 19.6 47 21.3 24 17.6
Postdates 336 18.5 299 20.5 33 14.9 4 2.9
Preeclampsia/hypertension 279 15.3 228 15.6 17 7.7 34 25.0
IUGR/oligohydramnios 280 15.4 231 15.8 24 10.9 25 18.4
IDDM/GDM - insulin 97 5.3 81 5.5 13 5.9 3 2.2
Large fetus 67 3.7 45 3.1 16 7.2 6 4.4
Maternal request 61 3.5 36 2.5 22 10.0 3 2.2
GDM, non-insulin 35 1.9 32 2.2 3 1.4 0 0
Intrahepatic cholestasis 43 2.4 35 2.4 5 2.3 3 2.2
Reduced fetal movements 40 2.2 36 2.5 3 1.4 1 0.7
Other maternal4 164 9.0 101 6.9 33 14.9 30 22.1
Other fetal5 59 3.2 51 3.5 5 2.3 3 2.2
Other Robson includes Robson groups 6, 7, 8 and 10. BMI= Body Mass Index. IQR=interquartile 
range. IDDM=insulin-dependent diabetes mellitus. GDM=gestational diabetes mellitus. 
PROM=prelabor rupture of membranes. IUGR=intrauterine growth restriction.1Missing 1.8%. 2Not 
assessed in 9.2%. 3More than one condition might be registered. 4Incl. twin pregnancy, previous 
obstetric history, chronic disease, prolonged latency phase, vaginal bleeding. 5incl. polyhydramnios, 
non-reassuring fetal tracing, known malformations, unknown gestational length.
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Table 2 Delivery mode after induction of labor in 1818 women with no prior vaginal birth 
according to obstetric group.
Cesarean section1 Operative vaginal Spontaneous vaginal
N  n % 95% CI n % 95% CI n % 95% CI
Nulliparous term 
cephalic
1461 320 21.9 19.8-24.1 314 21.5 19.4-23.7 827 56.6 54.0-59.2
Previous CS 221 89 40.3 33.7-47.1 40 18.1 13.3-23.8 92 41.6 35.1-48.4
Other Robson 136 50 36.8 28.9-45.8 28 20.6 14.2-28.6 60 44.1 35.9-53.2
All 1818 459 25.2 23.3-27.3 382 21.0 19.2-23.0 979 53.9 51.5-56.2
Other Robson includes Robson groups 6, 7, 8 and 10. 1Including cesarean section second twin.
Table 3 Main indication and subtype of 459 cesarean sections1 after induction of labor 
according to obstetric group.
    All Nulliparous 
term cephalic
 Previous CS Other Robson
n=459 % n=320 % n=89 % n=50 %
Main cesarean indication
Prolonged 1.stage 117 25.5 85 26.6 23 25.8 9 18.8
Prolonged 2. stage 26 5.7 19 5.9 4 4.5 3 6.5
Susp. fetal hypoxia 143 31.2 112 35.0 19 21.3 12 25.0
Failed induction 109 23.7 69 21.6 31 34.8 9 18.8
Uterine rupture 2 0.4 0 0 2 2.2 0 0
Abruptio placentae 5 1.1 3 0.9 1 1.1 1 2.1
Other 55 12.0 31 9.7 10 11.2 14 29.2
Subtype
Type 1 (immediate) 42 9.2 30 9.4 8 9.0 6 12.0
Type 2 (<20 minutes) 234 51.0 172 53.8 36 40.4 26 52.0
Type 3 (>20 minutes) 181 39.4 118 36.9 45 50.6 18 36.0
1Including cesarean section of second twin only (n=2). Other Robson includes Robson groups 6, 7, 8 
and 10. 
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Table 4 Induction methods in 1818 women with no prior vaginal birth according to obstetric 
group.
All Nulliparous term 
cephalic
Previous CS Other
Induction method N=1818 % N=1461 % N=221 % N=136 %
Foley start combinations
Foley alone 135 7.4 102 7.0 19 8.6 14 10.3
Foley + oral misoprostol  ± 
AT/oxytocin
191 10.5 178 12.2 4 1.8 9 6.6
Foley + insert misoprostol ± 
AT/oxytocin
198 10.9 190 13.0 1 0.5 7 5.1
Foley + vaginal misoprostol ± 
AT/oxytocin
213 11.7 177 12.1 11 5.0 25 18.4
Foley + dinoprostone ± 
AT/oxytocin
108 5.9 28 1.9 76 34.4 4 2.9
Foley ± AT/oxytocin 241 13.3 174 11.9 49 22.2 18 13.2
Misoprostol start combinations
Oral misoprostol alone 118 6.5 107 7.3 1 0.5 10 7.4
Oral misoprostol ± AT/oxytocin 45 2.5 41 2.8 0 0 4 2.9
Insert misoprostol alone 67 3.7 66 4.5 0 0 1 0.7
Insert misoprostol ± AT/oxytocin 29 1.6 28 1.9 0 0 1 0.7
Vaginal misoprostol alone 165 9.0 148 10.1 3 1.4 14 10.3
Vaginal misoprostol ± 
AT/oxytocin
88 4.8 79 5.4 1 0.5 8 5.9
Other combinations
Dinoprostone alone 39 2.1 9 0.6 26 11.8 4 2.9
Dinoprostone ± AT/oxytocin 11 0.6 2 0.1 8 3.6 1 0.7
Amniotomy ±oxytocin 130 7.2 103 7.0 19 8.6 8 5.9
Any misoprostol/dinoprostone + 
successive Foley ± AT/oxytocin
24 1.3 17 1.2 3 1.4 4 2.9
Other 16 0.9 12 0.8 0 0 4 2.9
Other Robson includes Robson groups 6, 7, 8 and 10. AT=amniotomy. 
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Table 5 Method and risk of cesarean section in nulliparous term cephalic and previous CS 
pregnancies after induction of labor.
                                   Proportion CS Risk of Caesarean section
CS % OR 95% CI p aOR2 a95% CI2 P2
1. Foley1 (n=1356)
Nulliparous term cephalic
Foley catheter 212 25.2 1.55 1.13-2.13 0.007 1.78 1.16-2.59 0.008
No Foley catheter 61 17.9 1 1
Previous CS
Foley catheter 60 40.3 1.08 0.46-2.54 0.86 0.63 0.19-2.07 0.45
No Foley catheter 10 38.5 1 1
2. Dinoprostone vs  misoprostol (n=1195)
Nulliparous term cephalic
Dinoprostone 14 34.1 1.80 0.93-3.49 0.082 1.49 0.74-3.01 0.26
Misoprostol 230 22.4 1 1
Previous CS
Dinoprostone 49 47.1 1.29 0.51-3.27 0.60 1.47 0.54-3.99 0.46
Misoprostol 9 40.9 1 1
1Excluding women with prelabor rupture of membranes. 2Adjusted for maternal age groups 16-24, 25-
34 (ref),
 ≥35; prepregnancy BMI, Bishop score ≤5 (ref), >5 and missing; Foley catheter yes/no, and 
birthweight in grams.
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Table 6 Maternal and fetal secondary outcomes after induction of labor according to obstetric 
groups.
All Nulliparous term 
cephalic
Previous CS Other
Maternal n % N % n % n %
Uterine rupture 2 0.1 0 0 2 0.9 0 0
Tachysystole 96 5.3 79 5.4 10 4.5 7 5.1
Epidural 1355 74.5 1090 74.6 157 71.0 108 79.4
Blood loss in ml
<500 1051 57.8 863 59.1 120 54.3 68 50.0
500-999 552 30.4 439 30.0 69 31.2 44 32.4
1000-1999 178 9.8 135 9.2 24 10.9 19 14.0
2000-2999 33 1.8 22 1.5 6 2.7 5 3.7
3000+ 4 0.2 2 0.1 2 0.9 0 0
Fetal1
Mean birthweight in grams 
(SD)
3485 (597) 3513 (550) 3664 (522) 2887 (808)
Adverse neonatal outcome2 203 11.2 139 9.5 22 10.0 42 30.9
Transfer NICU 132 7.4 85 5.9 10 4.6 37 27.6
Apgar <7 at 5 minutes 29 1.6 20 1.4 7 3.2 2 1.5
pH art umb <7.103 72 4.0 59 4.0 9 4.0 4 2.9
pH art umb <7.003 7 0.4 6 0.4 1 0.5 0 0
Other Robson includes Robson groups 6.7.8.and 10. 1Outcomes for first twin only. SD= standard 
deviation. 2Adverse neonatal outcome incl. pH arteria umbilicalis <7.10 and/or Apgar score at 5’ <7 
and/or transfer neonatal intensive care unit. NICU= neonatal intensive care unit excluding planned 
transfers (n=18). 3Missing 19.5%.
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Figure 1 Flowchart of participants 
160x170mm (150 x 150 DPI) 
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Supporting information Table S1. Indication for induction according to indication for CS in three 
obstetric groups.













Indication Postdates 27 6 24 13 1 1 6 78
PROM 14 5 17 6 0 0 6 48
Preeclampsia/hypertension 10 4 17 13 0 0 10 54
IUGR/oligohydramnios 9 0 19 9 0 2 1 40
IDDM/GDM, insulin 1 1 6 11 0 0 0 19
GDM, non-insulin 5 0 6 1 0 0 1 13
Other maternal 4 1 8 6 0 0 2 21
Reduced fetal movements 0 0 3 1 0 0 0 4
Intrahepatic cholestasis 2 0 1 0 0 0 1 4
Maternal request 2 1 1 0 0 0 2 6
Suspected large fetus 6 1 3 4 0 0 1 15
Other fetal 5 0 7 5 0 0 1 18
















Indication Postdates 4 0 3 4 0 0 2 13
PROM 5 0 3 8 0 0 4 20
Preeclampsia/hypertension 3 0 2 4 1 0 0 10
IUGR/oligohydramnios 2 0 3 3 0 0 0 8
IDDM/GDM, insulin 1 1 2 3 0 1 0 8
GDM, non-insulin 1 0 0 0 0 0 0 1
Other maternal 3 0 1 5 0 0 1 10
Reduced fetal movements 1 0 0 0 0 0 0 1
Maternal request 2 0 1 1 0 0 1 5
Suspected large fetus 1 3 2 2 0 0 2 10
Other fetal 0 0 2 1 0 0 0 3
Total 23 4 19 31 1 1 10 89













Indications Postdates 0 0 2 1 0 0 1 4
PROM 2 1 0 0 0 1 2 6
Preeclampsia/hypertension 1 0 3 1 0 0 4 9
IUGR/oligohydramnios 0 0 4 1 0 0 4 9
IDDM/GDM, insulin 2 0 0 1 0 0 0 3
Other maternal 2 2 2 2 0 0 3 11
Reduced fetal movements 0 0 0 1 0 0 0 1
Maternal request 0 0 0 1 0 0 0 1
Suspected large fetus 2 0 1 1 0 0 0 4
Total 9 3 12 9 0 1 14 48
PROM=prelabor rupture of membranes. IUGR=intrauterine growth restriction. IDDM=insulin-dependent diabetes mellitus. 
GDM=gestational diabetes mellitus.
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Supporting Figure 1 
Page 47 of 73
http://www.aogs-online.com
































































Induction of Labor and Nulliparity: A Nation-wide Clinical Practice Pilot Evaluation
Ingvil  Krarup Sørbye, MD PhD1, Kevin Sunde Oppegaard MD PhD2, Andrew Weeks MD PhD3, Kjersti 
Marsdal RM MSc1,4, Anne Flem Jacobsen MD PhD1, 5.  
1 Department of Obstetrics and Gynecology, Oslo University Hospital, Oslo, Norway
2 Department of Obstetrics and Gynecology, Finnmark Hospital Trust, Hammerfest, Norway
3 Liverpool Women's Hospital and University of Liverpool for Liverpool Health Partners, Liverpool, United 
Kingdom
4 Oslo Metropolitan University, Oslo, Norway
5 Faculty of Medicine, University of Oslo, Oslo, Norway
Correspondence:
Ingvil Krarup Sørbye, Department of Obstetrics and Gynecology, Oslo University Hospital, 
Sognsvannsveien 20, 0424 Oslo, Norway.
E-mail: isorbye@ous-hf.no
Telephone: +47 48186146
Page 48 of 73
http://www.aogs-online.com
































































The authors state that there are no conflicts of interest in connection with this article.
Page 49 of 73
http://www.aogs-online.com
































































A grant of NOK 210 000 was received from the Norwegian Medical Association’s fund for quality 
improvement and patient safety for a one-day seminar to present and discuss the project results for all 
participating birth units. The Research Council at Finnmark County Hospital, Hammerfest provided a grant 
of NOK 123 229 for KSO’s travel expenses in connection with this project.
Page 50 of 73
http://www.aogs-online.com

































































Induction of labor has become an increasingly common obstetric procedure. However, in nulliparous women 
or women with a previous cesarean section, induction of labor can pose a clinical challenge. Despite an 
overall expansion of medical indications for labor induction, there is little international consensus regarding 
the criteria for induction of labor, or for the recommended methods among nulliparous women. In this light, 
we assessed variations in the practice of induction of labor among 21 birth units in a nation-wide cohort of 
women with no prior vaginal birth.
Material and methods
We carried out a prospective observational pilot study of women with induced labor, and no prior vaginal 
birth, across 21 Norwegian birth units.  We registered induction indications, methods and outcomes from 
Sept 1st – Dec 31st 2018 using a web-based case record form. Women were grouped into ‘Nulliparous term 
cephalic’, ‘Previous CS’ and ‘Other Robson’ (Robson groups 6, 7, 8 or 10).
Results
More than 98% of eligible women (n=1818) were included. There was a wide variety of methods used for 
induction of labor. In nulliparous term cephalic pregnancies, cesarean section rates ranged from 11.1 - 
40.6% between birth units, whereas in the previous CS group, rates ranged from 22.7 - 67.5%. The 
indications ‘large fetus’ and ‘other fetal’ indications were associated with the highest cesarean rates. Failed 
inductions and failure to progress in labor contributed most to the cesarean rates. Uterine rupture occurred in 
two women (0.11%), both in the previous CS group. In neonates, 1.6% had Apgar <7 at 5 minutes, and 0.4% 
had an umbilical artery pH <7.00.
Conclusions
Cesarean rates and applied methods for induction of labor varied widely in this nation-wide cohort of 
women without a prior vaginal birth. Neonatal outcomes were similar to that of normal birth populations. 
Results could indicate the need to move towards more standardized induction protocols associated with 
optimal outcomes for mother and baby.
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Labor, Induced; Cesarean Section; Delivery, Obstetric; Nulliparous term cephalic; Robson, Clinical Audit.
Abbreviations
CS cesarean section
BMI body mass index
GDM gestational diabetes mellitus
IQR interquartile range
Key Message
In induction of labor among women without a prior vaginal birth, large variations in methods used and 
cesarean rates were observed in this nation-wide clinical practice evaluation.
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The worldwide rate of induction of labor has been rising steadily over the last 15 years.  Currently 
approximately 25 % of births in high-income countries are induced. (1, 2) When faced with unfavorable 
factors for the mother or the baby if pregnancy continues, induction of labor can be indicated. (3) In 
pregnancies complicated by maternal diabetes or preeclampsia, post-term pregnancies and prolonged 
prelabor rupture of membranes (PROM), induction of labor compared to expectant management reduces the 
risk of perinatal death and maternal complications. (3-7) Over the last decades an expansion of medical 
indications for labor induction has occurred, including such conditions as hypertensive disorders, (5) 
advanced maternal age, (8) gestational diabetes (GDM) (9) and suspected large fetus for gestation. (10) 
Newer studies have demonstrated the safety of induction of labor without a medical indication, with fetal 
outcomes and cesarean section (CS) rates comparable to rates among women awaiting spontaneous labor. 
(11) 
However, there are some concerns as to the generalizations of these findings into routine practice. First, 
results produced in setting with relatively high overall CS rates cannot necessarily be extrapolated to settings 
with average low CS rates. A clinical challenge is also posed by the considerable number of nulliparous 
women and women with a previous uterine scar, (12) giving birth today. Furthermore, induction of labor is 
not risk-free as more interventions are performed in induced compared to spontaneous labors. (13, 14) 
Finally, in recent studies of induction of labor, few have used standardized and consistent protocols in terms 
of the methods used. There is currently no international agreement as to what is the best induction method in 
women without a prior vaginal birth, (1, 15) and there is large diversity in clinical practice. (1, 2)
The authors of this study considered that assessing variation in induction practices in a national sample from 
a setting with free universal public delivery care and low average CS rates, (16) such as Norway, might be a 
good start to evaluate current practices and results. The aim of this pilot study was to examine variation in 
indications for induction of labor, methods and associated CS prevalence among women with no previous 
vaginal birth across 21 birth units nationwide. We used the Robson classification framework to distinguish 
women with nulliparous term cephalic pregnancies versus those with a previous uterine scar attempting a 
vaginal birth after cesarean section. (17) Ultimately, we aimed to identify practices associated with the best 
outcomes in terms of maternal and neonatal safety to inform obstetric providers. 
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We carried out a prospective pilot registration of women undergoing induction of labor with a live fetus 
beyond 23 completed gestational weeks and with no prior vaginal birth between September 1st - December 
31st 2018. We invited Norwegian obstetric departments with >1000 annual births to participate in the study. 
Out of 22 eligible units, 21 units were included (Supplementary Figure A). Participating units selected 
women whose labor was to be induced and decided upon the method(s) according to local practices, 
guidelines and definitions. Out-patient induction of labor was not practiced. Anonymous individual patient 
data were prospectively registered by clinicians in each department into a web-based electronic case record 
form. Only women with induction of labor were included. The number of nulliparous women without a 
previous birth and the induction rate during the period was also reported. The paper is reported using the 
STROBE guidelines for cohort studies.(18) Data were stored in Services for Sensitive Data, University of 
Oslo, Norway. The project is registered in ClinicalTrials.gov, no. NCT03730220.(19)
The primary outcome was the occurrence of cesarean section (CS) according to indication for induction and 
method of induction, stratified by obstetric group. Indications for CS were defined according to 
national/regional guidelines. We also assessed CS rates according to level of birth unit (university hospital 
or not). Secondary outcomes included uterine rupture, estimated maternal blood loss, adverse neonatal 
outcomes and the time interval from drug administration to birth. Estimated postpartum blood loss in ml was 
reported in categories. Adverse neonatal outcomes were defined as a composite outcome of Apgar score <7 
at 5 minutes and/or transfer to neonatal intensive care unit and/or pH in umbilical artery <7.10 within one 
hour of birth. 
We categorized cases into three groups. These were: “Nulliparous term cephalic” (Robson 2), "Previous CS" 
(classified as Robson 5: multiparous women with a previous uterine scar, with a single cephalic term 
pregnancy; however with no previous vaginal birth), and “Other Robson”  (including Robson groups 6 and 
7: women with a single breech pregnancy; Robson group 8: women with multiple pregnancies, and Robson 
group 10: women with a single cephalic pregnancy < 37 weeks’ gestation). 
The indication for induction was categorized into 12 groups: Postdates (as defined locally; latest 42+0), 
PROM, preeclampsia/hypertension, intrauterine growth restriction (IUGR)/oligohydramnios, insulin-treated 
diabetes in pregnancy including insulin-treated GDM, non-insulin treated GDM, suspected large fetus, 
reduced fetal movements, intrahepatic cholestasis of pregnancy, maternal request, ‘other maternal’ and 
‘other fetal’. The starting method for induction was categorized as Foley balloon catheter, misoprostol (oral, 
vaginal insert or vaginal tablet), or dinoprostone. As according to the protocol, we performed three 
comparisons: induction regime with Foley balloon catheter versus no catheter; induction regime including 
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misoprostol vaginal insert versus other misoprostol administration forms, and induction regime including 
dinoprostone versus misoprostol. 
Other covariates included maternal age in categories, pre-pregnancy body mass index (BMI) (< 30 or ≥30), 
gestational age at induction, Bishop score at induction ( ≤5, >5 or missing), epidural, infant birthweight and 
tachysystole (>5 contractions per 10” with abnormal fetal tracing). 
Statistical analysis
A statistical analysis plan included a power analysis. Assuming two groups of birth units with different 
induction methods resulting in a difference in CS rate between 20 to 25%, a significance level (α) of 0.05, 
and 80% power (β), the study would need 2182 participants. Applying the inclusion criteria, we estimated 
2250 births during the period. (20) Baseline characteristics and outcomes were summarized according to the 
obstetric group. Small cell numbers (n<10) were censored when calculating CS rates. For categorical 
outcomes we compared proportions with 95% CI with the Chi-Square test and/or Fisher’s exact test. We 
estimated the risk of CS by logistic regression analysis in generalized linear models adjusting for 
confounders as identified in the literature and according to biological plausibility, estimating crude and 
adjusted effect estimates as odds ratios (OR) with 95% CI with corresponding p-values. To check for 
linearity regarding continuous covariates, we also conducted analyses with log-transformed variables; 
however, the results did not change. We restricted analyses to nulliparous term cephalic and previous CS 
only due to small cell numbers. In sub analyses of CS deliveries only, we determined indications for the 
procedure and the subtype (type 1- immediate delivery; type 2- within 20-30 minutes or type 3 - within a 
given timeframe >30 min < 8 hours). Calculated P-values were two-sided and compared to a 5% 
significance level. Statistical analyses were performed in SPSS version 25 (IBM Corp. Released 2017. IBM 
SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.)
Ethical approval
All women received oral and written information about the study. As routine data were gathered 
anonymously, informed consent was waivered; however, women were able to opt out of the study upon 
request. The project was approved by the Norwegian Ethics Board, Region Health South East C, reference 
2018/1087 and each hospital’s Data Protection Officer.     
RESULTS
During the study period, a total of 7160 women without a prior vaginal birth gave birth in the 21 
participating departments. Among these, labor was induced in 1874 women (26.2%; range 11.7-34.3% 
between hospitals). Of all 1874 eligible women for inclusion in the study,1818 (98.5%) were included 
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(Figure 1). Most birth units had a written induction protocol; however, most were not differentiated 
according to their Robson group.
Nulliparous term cephalic pregnancies constituted 80.4% of births, followed by previous CS pregnancies 
(12.2%) (Table 1). The “Other Robson’ group included 52 twin pregnancies ( 2.9%), 59 preterm births 
(3.2%) and 25 planned breech births (1.4%). Overall, 20.3%  were aged 35 years or more and 18.4% had a 
pre-pregnancy BMI of 30 or more. Of all women, 16.6% had a registered comorbidity where 
preeclampsia/hypertension was most prevalent. PROM, postdate pregnancy and preeclampsia/hypertension 
were the most common indications for induction. Maternal request was an indication for induction in only 
3.5% of women.
In the nulliparous term cephalic group, one in five women gave birth by CS, whereas rates were doubled in 
the previous CS group and in the Other Robson group (Table 2). Hospital CS rates varied between 9.4% and 
45.5% in the nulliparous term cephalic group and between 31.3% and 54.5% in the previous CS group 
(Figure 2). In the whole cohort, university hospital CS rates did not differ significantly from non-university 
hospitals (24.2% vs 26.8%, P=0.22). In the nulliparous term cephalic group CS rates by indication for the 
induction of labor ranged from 11.1 to 40.6%, whereas in the previous CS group rates were overall higher 
and ranged from 22.7 to 67.5% (Figure 3; Table S1.). In the nulliparous term cephalic group ‘non-insulin 
GDM’, ‘other fetal’ and ‘large fetus’ were the indications associated with the highest CS rates (40.6-33.3%). 
In the previous CS group ‘large fetus’, ‘insulin-treated diabetes’ and ‘other fetal’ were associated with the 
highest CS rates (62.5-60.0%). 
The most common CS indication was suspected fetal hypoxia in the nulliparous term cephalic group, and 
failed induction in the previous CS group (Table 3). Of all cesarean procedures, 9.2% were reported as grade 
1 (immediate) (Table 3). Overall 2.1% of women in the nulliparous term cephalic group and 3.6% of the 
previous CS group experienced an immediate CS. Suspected uterine rupture or abruptio placentae were 
indications for seven (0.4%) cesarean procedures. 
The most common methods for induction are presented in Table 4. In the nulliparous term cephalic group, a 
combination of Foley + misoprostol was the most common initiation method (37.3%), followed by Foley + 
amniotomy/oxytocin (11.9%) (Table 4). In the previous CS group, most women received Foley + 
dinoprostone (34.4%), followed by Foley + amniotomy/oxytocin. However, altogether, more than 40 
different method combinations and sequences were registered.
Use of Foley catheter was associated with birth by CS in the nulliparous term cephalic group (aOR 1.78, 
95% CI 1.16-2.59, p=0.008), but not in the previous CS group (aOR 0.63, 95% CI 0.19-2.07, P=0.45) ( 
Table 5). Use of dinoprostone showed a borderline significant association with birth by CS compared to 
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misoprostol in crude, but not in adjusted analyses. There was no association between route of administration 
of misoprostol and risk of CS (data not shown).
Uterine rupture occurred in two women (0.11%), both in the previous CS group (Table 6). Maternal blood 
loss differed between groups (p=0.049, Chi-Square); however, tachysystole did not. The composite adverse 
infant outcome occurred in 9.5% and 10.0% in the nulliparous term cephalic and the previous CS group 
respectively. A higher proportion (30.9%) was found in the Other Robson groups due to more transfers to 
the neonatal ward due to prematurity. Overall 29 infants (1.6%) had an Apgar score of less than 7 at 5’. 
Seven infants (0.4%) had an umbilical artery pH<7.00, of whom one infant was transferred to the neonatal 
ward. The method of induction was not associated with adverse maternal or neonatal outcome. 
Among nulliparous term cephalic births, 26.5% were still undelivered 48 hours after induction start, as were 
31.6% in the previous CS group and 26.5% in the Other Robson group (data not shown). In the three groups 
median duration from start of induction to birth were 32.6 hours (IQR 31.8), 34.1 hours (IQR 35.1) and 30.6 
hours (IQR 32.6), respectively. 
DISCUSSION
Our study showed large variations in the practice and results of induction of labor in this nation-wide 
sample. The frequency of CS after induction of labor was highest in the previous CS group, where about two 
out of five women gave birth by CS and lowest in the nulliparous term cephalic group, where about one out 
of five women gave birth by CS. CS rates after induction differed widely between units. CS performed due 
to failed induction of labor and prolonged first stage of labor accounted for nearly half of all CS. Our study 
found a wide variation of induction methods, with few units using standard induction protocols. Maternal 
and fetal safety outcomes were comparable to existing literature.  
The strengths of this pilot study include the nation-wide prospective design with more than 98% of eligible 
women included. We had access to detailed information regarding indications, the methods used, including 
the order and route of administration, as well as important safety and efficiency outcomes.
One of the limitations of the study is that we lacked control data from induced multiparous women as well 
as on spontaneous labors. For this reason, we cannot comment on whether induction increases the rate of CS 
or adverse outcomes compared to spontaneous birth. Furthermore, we lacked detailed data on the local birth 
units, such as the number of referrals, socioeconomic spread etc. that might influence outcomes in terms of 
mode of birth. In the previous CS group we lacked information regarding the previous birth. However, CS 
rates were slightly lower in tertiary referral university hospitals compared to non-university hospitals, where 
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an accumulation of risks would be expected. Finally, our observational design does not warrant causal 
inference. 
Induction by “large fetus” indication revealed high rates of CS in our study. However, the CS rate at 33.3% 
is similar to other studies of induction in woman with ‘large babies. In the comprehensive study by Boulvain 
et al, (10) there was a CS rate of 28%, even though 53% were parous. These rates might be the result of a 
high gestational age in combination with maternal diabetic comorbidity. GDM non-insulin comorbidity had 
the highest CS rate whereas insulin-treated pregestational or gestational diabetes comorbidity had a 
relatively low CS rate in nulliparous term cephalic pregnancies.  In Norway, insulin users are induced 
between week 38 and 40, but non-insulin GDM are induced primarily on additional indications. (21)
“Other fetal indication” for induction of labor had one of the highest CS rates in both nulliparous term 
cephalic and previous CS pregnancies. This is a mixed group including fetal malformations, 
polyhydramnios, non-reassuring antenatal fetal tracing and unknown gestational length. Polyhydramnios 
may give insufficient contractions due to an over distended uterus (22) and non-reassuring fetal tracing have 
to be handled with care; delivery, rather than expectant management is preferred, if it continues. The group 
“maternal request” was surprisingly low with 3.5 % of all inductions and we found a low CS rate both in the 
nulliparous term cephalic and the previous CS group.  This is lower than previously reported. (23) The 
distinction between ‘maternal request’ or ‘medical problem’ can be a fine one, especially when considering 
mental health and pregnancy complaints. However, this finding indicates a restrictive attitude among 
providers, in contrast to upcoming trends elsewhere. (24) 
The overall proportion of failed induction and prolonged first stage was unexpectedly high in our sample. 
However, as 27-32% of women were undelivered 48 hours after the start of induction, this is not likely to 
reflect a use of rigid time limits.  The 22-35% rate of failed induction/poor progress in the first stage that we 
found in our sample might imply a practice emphasizing safety rather than effectiveness. This is also 
reflected in a relatively low uterine rupture rate, a low tachysystole rate of 5% and few immediate CS 
procedures.  
At present, there are conflicting reports of how and when induction of labor should be offered to women. 
Trials have been conducted among women at term with no medical indication. (11, 25, 26) These 
randomized trials indicate no major safety concerns in terms of the CS risk or adverse infant or maternal 
outcomes. In addition, although the ARRIVE trial has been criticized as including many overweight and 
obese women, (27) the 18.6% CS rate in the trial’s induced group (who were all low risk nulliparous 
women) is similar to the 16.7% rate seen in ‘maternal request’ in the nulliparous term cephalic group in our 
study. A Cochrane review looking at induction at 40 weeks versus expectant management found improved 
outcomes in the induction group, except for a higher operative vaginal delivery rate. (3) However, a 
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prerequisite in generalizing findings is that the induction process and labor is well managed with the 
necessary staff at hand. Like most high-resource countries, Norway has a rapidly increasing induction rate 
that reached 23% of all births in 2018 (20), but at the same time, overall CS rates - 16.0% in 2017 – are the 
second lowest rate across the OECD area (16). However, CS rates vary considerably between regions 
beyond what can be expected due to case-mix. (28) A national induction guideline lists medical indications 
and methods, but leaves the choice among these methods to individual departments and staff. (21) In this 
clinical practice evaluation, we found that multiple induction protocols are used even within nulliparous 
term cephalic and previous CS groups. What this means is that women across the country do not have 
similar treatment when undergoing induction of labor. 
Translating RCT evidence into practical clinical protocols can be challenging in obstetric units facing 
logistical restraints such as delays in timely administration of uterotonics and performing rupture of 
membranes. (29) Results from practice evaluations are therefore important to inform decisions in induction 
regimes tailored to specific groups. Women should be offered joint decision making based on these facts. 
Careful selection of women for induction who have previously had a cesarean section, as well as taking 
women’s preferences into account, are important factors in a pragmatic induction of labor protocol. 
CONCLUSION
A wide variation of induction methods and CS rates after induction, as well as a high rate of failed 
inductions in women without a prior vaginal birth, points to a potential for improvement by moving towards 
more standardized protocols. The Robson groups provide a framework for the counselling of women about 
particular risks and benefits regarding induction of labor while working towards shared decision-making.
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Tweetable abstract: 
There is considerable variation in outcomes after induction of labor, depending on where a primiparous 
woman chooses to have her birth.  
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Legends of supporting information
Supporting Information Figure 1 Map of participating birth units in Norway.
Legends of Tables and Figures
Table 1 Maternal characteristics in 1818 women with no prior vaginal birth undergoing induction of labor.
Table 2 Delivery mode after induction of labor in 1818 women with no prior vaginal birth according to 
obstetric group.
Table 3 Main indication and subtype of 459 cesarean sections1 after induction of labor according to obstetric 
group.
Table 4 Induction methods in 1818 women with no prior vaginal birth according to obstetric group. 
Table 5 Method and risk of cesarean section in nulliparous term cephalic and previous CS pregnancies after 
induction of labor.
Table 6 Maternal and fetal secondary outcomes after induction of labor according to obstetric groups.
Supporting information Table S1. Indication for induction according to indication for CS in three obstetric 
groups.
Figure 1 Flowchart of study participants
Figure 2 Proportions of cesarean section after induction of labor by delivery unit in nulliparous term 
cephalic (a) and previous CS pregnancies (b).
Figure 3 Cesarean section rates according to indication for induction of labor 
in nulliparous term cephalic and previous CS pregnancies.
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Table 1 Maternal characteristics in 1818 women with no prior vaginal birth undergoing induction of labor.
All Nulliparous 
term cephalic
Previous CS Other 
Robson






























<30 1458 81.6 1185 82.3 160 74.8 113 85.0
>= 30 328 18.4 254 17.7 54 25.2 20 15.0
Bishops score2
0-5 1366 82.8 1077 81.8 185 88.9 104 83.2
6-10 284 17.2 240 18.2 23 11.1 21 16.8
Birth at University hospital 
Yes 1173 64.5 957 65.5 124 56.1 93 68.4
Gest. age median (IQR) 40+1 (21) 40+3 (18) 40+0 (18) 36+5 (16)
Maternal comorbidity3
IDDM/GDM insulin 137 7.5 105 7.2 22 10.0 10 7.4
GDM, non-insulin 91 5.0 74 6.4 7 3.2 10 7.4
Preeclampsia/ hypertension 238 13.1 189 12.9 13 5.9 37 27.2
Intrahepatic cholestasis 34 1.9 25 1.7 6 2.7 3 2.2
Another comorbidity 272 15.0 210 14.4 39 17.6 23 5.9
Decision induction
Consultant 1181 65.0 897 61.4 162 72.4 123 90.4
Resident 534 29.4 472 32.3 49 22.2 13 9.6
Midwife 103 5.7 93 6.4 10 4.5 0 0
Main indication for induction
PROM 357 19.3 286 19.6 47 21.3 24 17.6
Postdates 336 18.5 299 20.5 33 14.9 4 2.9
Preeclampsia/hypertension 279 15.3 228 15.6 17 7.7 34 25.0
IUGR/oligohydramnios 280 15.4 231 15.8 24 10.9 25 18.4
IDDM/GDM - insulin 97 5.3 81 5.5 13 5.9 3 2.2
Large fetus 67 3.7 45 3.1 16 7.2 6 4.4
Maternal request 61 3.5 36 2.5 22 10.0 3 2.2
GDM, non-insulin 35 1.9 32 2.2 3 1.4 0 0
Intrahepatic cholestasis 43 2.4 35 2.4 5 2.3 3 2.2
Reduced fetal movements 40 2.2 36 2.5 3 1.4 1 0.7
Other maternal4 164 9.0 101 6.9 33 14.9 30 22.1
Other fetal5 59 3.2 51 3.5 5 2.3 3 2.2
Other Robson includes Robson groups 6, 7, 8 and 10. BMI= Body Mass Index. IQR=interquartile range. 
IDDM=insulin-dependent diabetes mellitus. GDM=gestational diabetes mellitus. PROM=prelabor rupture of 
membranes. IUGR=intrauterine growth restriction.1Missing 1.8%. 2Not assessed in 9.2%. 3More than one condition 
might be registered. 4Incl. twin pregnancy, previous obstetric history, chronic disease, prolonged latency phase, 
vaginal bleeding. 5incl. polyhydramnios, non-reassuring fetal tracing, known malformations, unknown gestational 
length.
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Table 2 Delivery mode after induction of labor in 1818 women with no prior vaginal birth according to 
obstetric group.
Cesarean section1 Operative vaginal Spontaneous vaginal
N  n % 95% CI n % 95% CI n % 95% CI
Nulliparous term cephalic 1461 320 21.9 19.8-24.1 314 21.5 19.4-23.7 827 56.6 54.0-59.2
Previous CS 221 89 40.3 33.7-47.1 40 18.1 13.3-23.8 92 41.6 35.1-48.4
Other Robson 136 50 36.8 28.9-45.8 28 20.6 14.2-28.6 60 44.1 35.9-53.2
All 1818 459 25.2 23.3-27.3 382 21.0 19.2-23.0 979 53.9 51.5-56.2
Other Robson includes Robson groups 6, 7, 8 and 10. 1Including cesarean section second twin.
Table 3 Main indication and subtype of 459 cesarean sections1 after induction of labor according to obstetric 
group.
    All Nulliparous 
term cephalic
 Previous CS Other Robson
n=459 % n=320 % n=89 % n=50 %
Main cesarean indication
Prolonged 1.stage 117 25.5 85 26.6 23 25.8 9 18.8
Prolonged 2. stage 26 5.7 19 5.9 4 4.5 3 6.5
Susp. fetal hypoxia 143 31.2 112 35.0 19 21.3 12 25.0
Failed induction 109 23.7 69 21.6 31 34.8 9 18.8
Uterine rupture 2 0.4 0 0 2 2.2 0 0
Abruptio placentae 5 1.1 3 0.9 1 1.1 1 2.1
Other 55 12.0 31 9.7 10 11.2 14 29.2
Subtype
Type 1 (immediate) 42 9.2 30 9.4 8 9.0 6 12.0
Type 2 (<20 minutes) 234 51.0 172 53.8 36 40.4 26 52.0
Type 3 (>20 minutes) 181 39.4 118 36.9 45 50.6 18 36.0
1Including cesarean section of second twin only (n=2). Other Robson includes Robson groups 6, 7, 8 and 10. 
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Table 4 Induction methods in 1818 women with no prior vaginal birth according to obstetric group.
All Nulliparous term 
cephalic
Previous CS Other
Induction method N=1818 % N=1461 % N=221 % N=136 %
Foley start combinations
Foley alone 135 7.4 102 7.0 19 8.6 14 10.3
Foley + oral misoprostol  ± AT/oxytocin 191 10.5 178 12.2 4 1.8 9 6.6
Foley + insert misoprostol ± AT/oxytocin 198 10.9 190 13.0 1 0.5 7 5.1
Foley + vaginal misoprostol ± AT/oxytocin 213 11.7 177 12.1 11 5.0 25 18.4
Foley + dinoprostone ± AT/oxytocin 108 5.9 28 1.9 76 34.4 4 2.9
Foley ± AT/oxytocin 241 13.3 174 11.9 49 22.2 18 13.2
Misoprostol start combinations
Oral misoprostol alone 118 6.5 107 7.3 1 0.5 10 7.4
Oral misoprostol ± AT/oxytocin 45 2.5 41 2.8 0 0 4 2.9
Insert misoprostol alone 67 3.7 66 4.5 0 0 1 0.7
Insert misoprostol ± AT/oxytocin 29 1.6 28 1.9 0 0 1 0.7
Vaginal misoprostol alone 165 9.0 148 10.1 3 1.4 14 10.3
Vaginal misoprostol ± AT/oxytocin 88 4.8 79 5.4 1 0.5 8 5.9
Other combinations
Dinoprostone alone 39 2.1 9 0.6 26 11.8 4 2.9
Dinoprostone ± AT/oxytocin 11 0.6 2 0.1 8 3.6 1 0.7
Amniotomy ±oxytocin 130 7.2 103 7.0 19 8.6 8 5.9
Any misoprostol/dinoprostone + successive 
Foley ± AT/oxytocin
24 1.3 17 1.2 3 1.4 4 2.9
Other 16 0.9 12 0.8 0 0 4 2.9
Other Robson includes Robson groups 6, 7, 8 and 10. AT=amniotomy. 
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Table 5 Method and risk of cesarean section in nulliparous term cephalic and previous CS pregnancies after 
induction of labor.
                                   Proportion CS Risk of Caesarean section
CS % OR 95% CI p aOR2 a95% CI2 P2
1. Foley1 (n=1356)
Nulliparous term cephalic
Foley catheter 212 25.2 1.55 1.13-2.13 0.007 1.78 1.16-2.59 0.008
No Foley catheter 61 17.9 1 1
Previous CS
Foley catheter 60 40.3 1.08 0.46-2.54 0.86 0.63 0.19-2.07 0.45
No Foley catheter 10 38.5 1 1
2. Dinoprostone vs  misoprostol (n=1195)
Nulliparous term cephalic
Dinoprostone 14 34.1 1.80 0.93-3.49 0.082 1.49 0.74-3.01 0.26
Misoprostol 230 22.4 1 1
Previous CS
Dinoprostone 49 47.1 1.29 0.51-3.27 0.60 1.47 0.54-3.99 0.46
Misoprostol 9 40.9 1 1
1Excluding women with prelabor rupture of membranes. 2Adjusted for maternal age groups 16-24, 25-34 (ref),
 ≥35; prepregnancy BMI, Bishop score ≤5 (ref), >5 and missing; Foley catheter yes/no, and birthweight in grams.
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Table 6 Maternal and fetal secondary outcomes after induction of labor according to obstetric groups.
All Nulliparous term cephalic Previous CS Other
Maternal n % N % n % n %
Uterine rupture 2 0.1 0 0 2 0.9 0 0
Tachysystole 96 5.3 79 5.4 10 4.5 7 5.1
Epidural 1355 74.5 1090 74.6 157 71.0 108 79.4
Blood loss in ml
<500 1051 57.8 863 59.1 120 54.3 68 50.0
500-999 552 30.4 439 30.0 69 31.2 44 32.4
1000-1999 178 9.8 135 9.2 24 10.9 19 14.0
2000-2999 33 1.8 22 1.5 6 2.7 5 3.7
3000+ 4 0.2 2 0.1 2 0.9 0 0
Fetal1
Mean birthweight in 
grams(SD)
3485 (597) 3513 (550) 3664 (522) 2887 (808)
Adverse neonatal outcome2 203 11.2 139 9.5 22 10.0 42 30.9
Transfer NICU 132 7.4 85 5.9 10 4.6 37 27.6
Apgar <7 at 5 minutes 29 1.6 20 1.4 7 3.2 2 1.5
pH art umb <7.103 72 4.0 59 4.0 9 4.0 4 2.9
pH art umb <7.003 7 0.4 6 0.4 1 0.5 0 0
Other Robson includes Robson groups 6.7.8.and 10. 1Outcomes for first twin only. SD= standard deviation. 2Adverse 
neonatal outcome incl. pH arteria umbilicalis <7.10 and/or Apgar score at 5’ <7 and/or transfer neonatal intensive care 
unit. NICU= neonatal intensive care unit excluding planned transfers (n=18). 3Missing 19.5%.
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Figure 1 Flowchart of study participants
Not asked n=20
Did not consent n=8
21 delivery units >1000 births/year





n=1 874 (26.2%) 
Duplicate records    n=26
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Figure 2 Proportions of cesarean section after induction of labor by delivery unit in nulliparous term 
cephalic (a) and previous CS pregnancies (b).
(a) Nulliparous term cephalic 







































Other Robson includes Robson groups 6, 7,8 and 10. Results from delivery units with n<10 deliveries per cell are 
censored.
Page 70 of 73
http://www.aogs-online.com































































Figure 3 Cesarean section rates according to indication for induction of labor 
























































Previous CS                                                        Cesarean section (%)
GDM= gestational diabetes mellitus; IDDM= insulin-dependent diabetes mellitus; IUGR=intrauterine growth 
restriction; PROM=prelabor rupture of membranes; ICP= intrahepatic cholestasis of pregnancy. 
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Supporting information Table S1. Indication for induction according to indication for CS in three obstetric groups.













Indication Postdates 27 6 24 13 1 1 6 78
PROM 14 5 17 6 0 0 6 48
Preeclampsia/hypertension 10 4 17 13 0 0 10 54
IUGR/oligohydramnios 9 0 19 9 0 2 1 40
IDDM/GDM-insulin 1 1 6 11 0 0 0 19
GDM, non-insulin 5 0 6 1 0 0 1 13
Other maternal 4 1 8 6 0 0 2 21
Reduced fetal movements 0 0 3 1 0 0 0 4
Intrahepatic cholestasis 2 0 1 0 0 0 1 4
Maternal request 2 1 1 0 0 0 2 6
Suspected large fetus 6 1 3 4 0 0 1 15
Other fetal 5 0 7 5 0 0 1 18
















Indication Postdates 4 0 3 4 0 0 2 13
PROM 5 0 3 8 0 0 4 20
Preeclampsia/hypertension 3 0 2 4 1 0 0 10
IUGR/oligohydramnios 2 0 3 3 0 0 0 8
IDDM/GDM-insulin 1 1 2 3 0 1 0 8
GDM, non-insulin 1 0 0 0 0 0 0 1
Other maternal 3 0 1 5 0 0 1 10
Reduced fetal movements 1 0 0 0 0 0 0 1
Maternal request 2 0 1 1 0 0 1 5
Suspected large fetus 1 3 2 2 0 0 2 10
Other fetal 0 0 2 1 0 0 0 3
Total 23 4 19 31 1 1 10 89













Indications Postdates 0 0 2 1 0 0 1 4
PROM 2 1 0 0 0 1 2 6
Preeclampsia/hypertension 1 0 3 1 0 0 4 9
IUGR/oligohydramnios 0 0 4 1 0 0 4 9
IDDM/GDM-insulin 2 0 0 1 0 0 0 3
Other maternal 2 2 2 2 0 0 3 11
Reduced fetal movements 0 0 0 1 0 0 0 1
Maternal request 0 0 0 1 0 0 0 1
Suspected large fetus 2 0 1 1 0 0 0 4
Total 9 3 12 9 0 1 14 48
PROM=prelabor rupture of membranes. IUGR=intrauterine growth restriction. IDDM/GDM=insulin-dependent/gestational diabetes.
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Supporting Information Figure 1 Map of participating birth units in Norway.
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